Becker's Healthcare February 1, 2024
Feb.1 marks the first day that federal officials will negotiate the price for 10 of the most expensive drugs as part of the Biden administration’s Inflation Reduction Act, The Hill reported.
Companies will have one month to either accept or reject and counteroffer prices for the 10 drugs.
In August 2023, the HHS announced the 10 drugs it would begin negotiating — which in total cost Medicare enrollees $3.4 billion in out-of-pocket costs in 2022 alone.
The 10 drugs included in the first round of negotiations are: Eliquis, Jardiance, Xarelto, Januvia, Farxiga, Entresto, Enbrel, Imbruvica, Stelara and Fiasp (as well as related Fiasp varieties).
Drug companies have opposed the new rule allowing for negotiation since it could lead...
Today's Sponsors
Today's Sponsor